On the other hand, recent work from our group demonstrated that mice lacking urokinase-type plasminogen activator (Plau−/−) or plasminogen (Plg−/−) were not protected from ENaC activation and sodium retention in experimental nephrotic syndrome [8, 36]. This evidence concerns the gene PLAU and nephrotic syndrome.